HOME >> BIOLOGY >> NEWS
African-Americans more likely to lose limbs due to vascular disease than other groups

Researchers at the Johns Hopkins physical medicine and rehabilitation department report that African Americans with vascular disease are up to four times more likely to have lower limb amputations than those of other groups with the same medical conditions.

The findings, reported in the September issue of the Archives of Physical Medicine and Rehabilitation, reveal that African Americans accounted for approximately 40 percent of the state's lower limb dysvascular amputations, or amputations required because of blood vessel disease. African-Americans also were more likely to have amputations at higher levels than whites, for example, while 34 percent of African-Americans underwent above knee amputations, only 27 percent of whites had the same procedure.

"Rising rates of lower limb amputations in the general population combined with disproportionately higher rates among African Americans are concerning and warrant further investigation into their underlying causes and consequences," says Timothy R. Dillingham, M.D., lead author of the study and associate professor in the Johns Hopkins' physical medicine and rehabilitation department. "We need to better understand the causes of racial differences in amputation rates and policy makers need to identify and promote public health initiatives that alleviate the excess risk of limb loss the among minority populations."

Dillingham and his team analyzed information on 27,149 Maryland hospital patients from 1986 to 1997 who required lower limb amputations due to vascular disease. Patients excluded from the study sample included those who had a lower limb amputation due to trauma, including fractures, crash and burn injuries, bone or soft tissue malignancy, or congenital anomalies.

Rates for dysvascular amputations increased from 41.4 per 100,000 in 1986 to 47.2 per 100,000 in 1997. For all levels of amputation, annual rates of amputation among African Americans were two to four times higher
'"/>

Contact: John Lazarou
jlazaro1@jhmi.edu
410-502-8902
Johns Hopkins Medical Institutions
10-Sep-2002


Page: 1 2

Related biology news :

1. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
2. Whites, African-Americans better rate medical care experiences when seeing same-race physicians
3. Does a new hypothesis help explain higher levels of hypertension among African-Americans?
4. U-M researchers seek answers for African-Americans at risk for prostate cancer
5. Gene variant increases risk of cardiac arrhythmia for African-Americans
6. Gene mutation tied to deafness found in African-Americans and Caucasians
7. Study Finds Gene Is Associated With Higher Risk Of One Kind of Stroke Among African-Americans
8. Complex cells likely arose from combination of bacterial and extreme-microbe genomes
9. Goals unlikely to protect Gulf of Mexico shrimp industry
10. Manatee population rising in some regions, likely stalled or declining in others
11. Natures ambush: pregnancy more likely from single unprotected intercourse than believed

Post Your Comments:
(Date:6/17/2015)... Deutschland und GERMANTOWN, Maryland , June ... ®   Produktlinie mit DNA-Tests verbessert den ... (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) hat ... STR-Testkits der Produktlinie Investigator ® ... Markt eingeführt. Die neuen Kits zur Erstellung genetischer Fingerabdrücke ...
(Date:6/16/2015)... , June 16, 2015  With the increasing ... security remains a top concern. The recent compromise of ... the need for strong authentication within government agencies. ... a biometric one-time password (OTP) authenticator, has been submitted ... (FIPS) 140-2 Level 3 validation for tamper proofing. ...
(Date:6/15/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market, announces that its leading payment security technology, the ... Experience! @ NYC June 18th. Digital Experience! @ ... in technology to over 300 of the top media covering ... Pavilion in New York City from ...
Breaking Biology News(10 mins):QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3
(Date:7/1/2015)... 1, 2015   Decision Resources Group ... of Otezla are its oral administration, alternative mechanism ... by surveyed rheumatologists. Otezla was the first oral ... of active psoriatic arthritis in the ... care includes conventional oral treatments including disease-modifying antirheumatic ...
(Date:7/1/2015)... July 1, 2015  Axovant Sciences Ltd. (NYSE: ... the treatment of dementia, today announced that the ... 22 at 5:45 p.m. EDT following its presentation ... International Conference 2015 (AAIC). The ... , Dr. Lawrence Friedhoff , Chief Development ...
(Date:7/1/2015)... ... July 01, 2015 , ... Apex Therapeutics announced today that company ... Philadelphia, PA. , The presentation took place on Tuesday, June 16 and ... the development of APX3330 for the treatment of pancreatic cancer. A copy of ...
(Date:6/30/2015)... ... June 30, 2015 , ... Students and faculty from ... first half of “Integrative Biotechnology,” an applied biotechnology course team-taught by faculty members ... course combines students from both universities and is taught on both continents. , ...
Breaking Biology Technology:Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2
Cached News: